Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Patients

LB Li-hua Bian
MW Min Wang
JG Jing Gong
HL Hong-hong Liu
NW Nan Wang
NW Na Wen
WF Wen-sheng Fan
BX Bai-xuan Xu
MW Ming-yang Wang
MY Ming-xia Ye
YM Yuan-guang Meng
request Request a Protocol
ask Ask a question
Favorite

This retrospective study was approved by the institutional review board, and the need for patient informed consent was waived (Ethical Application Ref: GH301-18052). Our primary patient selection criteria was pathologically proven diagnoses of endometrial cancer patients who underwent pretreatment 18F-FDG PET/CT or integrated18F-FDG PET/MRI for initial staging between April 2013 and May 2018. According to the primary criteria, 81 consecutive patients were selected. Of these, 37 patients underwent the 18F-FDG PET/CT scanning, and 44 patients underwent the integrated 18F-FDG PET/MRI scanning.

Copyright and License information:  ©2019 Bian et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A